Showing results (251-260 of 288) with videos related to
Sort By:
Pageof 29
Prostate Cancer and Prostatic Diseases|June 15, 2005
Risk factors for disease progression in patients with lower urinary tract symptoms/benign prostatic hyperplasia (LUTS/BPH): a systematic analysis of expert opinionF C Lowe, J Batista, R Berges, et al.Current Oncology (Toronto, Ont.)|January 5, 2019
The Prostate Cancer Rehabilitation Clinic: a biopsychosocial clinic for sexual dysfunction after radical prostatectomyA Matthew, N Lutzky-Cohen, L Jamnicky, et al.The Journal of Rheumatology|October 1, 1994
Selective expression of V beta families by T cells in the blood and salivary gland infiltrate of patients with primary Sjögren's syndromeM D Smith, A Lamour, A Boylston, et al.Heliyon|June 7, 2024
Association of clinical and imaging characteristics with pulmonary function testing in patients with Long-COVIDLin-Mei Zhao, Andrew C Lancaster, Ritesh Patel, et al.Cell Reports|February 9, 2017
Identification of a Sgo2-Dependent but Mad2-Independent Pathway Controlling Anaphase Onset in Fission YeastJohn C Meadows, Theresa C Lancaster, Graham J Buttrick, et al.Genome Biology|July 2, 2024
Benchmarking computational variant effect predictors by their ability to infer human traitsDaniel R Tabet, Da Kuang, Megan C Lancaster, et al.The Journal of Urology|September 18, 2007
Vascular targeted photodynamic therapy with palladium-bacteriopheophorbide photosensitizer for recurrent prostate cancer following definitive radiation therapy: assessment of safety and treatment responseJ Trachtenberg, A Bogaards, R A Weersink, et al.Methods in Molecular Biology (Clifton, N.J.)|December 2, 2011
A primer on the current state of microarray technologiesAlexander J Trachtenberg, Jae-Hyung Robert, Azza E Abdalla, et al.Circulation Research|May 26, 2022
Arrhythmias as Presentation of Genetic CardiomyopathyJ Lukas Laws, Megan C Lancaster, M Ben Shoemaker, et al.Prostate Cancer and Prostatic Diseases|December 10, 2014
Diagnostic prostate biopsy performed in a non-academic center increases the risk of re-classification at confirmatory biopsy for men considering active surveillance for prostate cancerL M Wong, S Ferrara, S M H Alibhai, et al.Pageof 29